Day 2 ESC : Part-2 : BB in post MI no heart failure studies : REBOOT- MI: Post MI with EF more than 40%, Beta blocker is not associated with reduction in death or MI or Ischemic events BETAMI- DANBLOCK: BB helps in pts with MI w/o heart failure REBOOT/ BETAMI DANBLOCK/CAPITAL RCT: IPD Metanalysis: BB helps in post MI in reducing MACE. REFINe-ICD: ICD in patients with LVEF 36%-50% with abnormal markers ( Holster abnormal Heart rate turbulence and T-wave alternans) : No use of ICD in reducing all cause mortality or CV death or sudden death. @RameshSank1975 @escardio @NEJM #ESCCongress @SRIHER_Official @SRMC_official

Day 2 ESC 2025 DAPA ACT HF -TIMI-38: - No benefit of initiating DAPA in hospitalized HF pts through two months ( underpowered ) ; However, it’s safe . A Metanalysis of Empulse , SOLOIST and DAPA ACT HF showed benefit emphasizing the importance of continuing what we do at present . VICTOR : Vericiguat did not reduce CV death or first HHF in ambulatory HF (without hospital admission in prior 3 months). However, it reduced CV death ( powered for the event ) ODYSSEY HCM: No use of Mavacampten in Non Ob HCM in reducing pVO2 or KCCQ score MAPLE HCM : Aficamten is better than metoprolol in oHCM in improving pVO2 , NYHA class and KCCS score @escardio @ESC_Journals @NEJM @circulation #ESCCongress #ESCCongress2025 @SRIHER_Official @SRMC_official @RameshSank1975

CHIP mutations in Indian CAD patients . Presented at ESC,2025. @ICMRDELHI @SRIHER_Official @SRMC_official #ESCCongress @escardio

Treatment goals for low-density lipoprotein cholesterol across categories of total cardiovascular risk! Read the NEW ESC GUIDELINES 2025 in #EHJ! academic.oup.com/eurheartj/a… #dyslipidaemias #cardiovascular #risk #EHJ #Cardiotwitter #ESCCongress #guidelines @ESC_journals @escardio

Dr. @georgedangas will present on machine learning models with established risk scores at #ESCCongress 2025 with #WCCardio. Gain insights into the latest advancements. #CardioX @escardio @IcahnMountSinai

Day 1 ESC 2025 POTCAST : Keep K between 4.5-5 AMALFI: Screening for AFib by extended patch helps in reducing stroke DIGIT-HF: Digitoxin in HFrEF : Reduces Death or HFH Double Choice : 2/2 factorial study ; LA vs MAC / AcuN2Vs EvolP: LA is non inferior : AcuN2 s non inferior to EP @ESC_Journals #ESCCongress @SRIHER_Official @SRMC_official

Amazing crowd! The largest Cardiology meeting in the world! @ESC_Journals #esccongress #wcc @SRIHER_Official Starting LBCT with POTCAST trial. Keep the K between 4.5-.5.

New in #JACCINT: International cohort 🌍 of severe AS pts shows BAV-0 after #TAVR had better 5-year survival 📈 vs BAV-1 & TAV. Valve choice matters: self-expanding valves outperformed balloon-expandable valves for long-term outcomes ⏳✅ jacc.org/doi/10.1016/j.jcin.… #vhdAS

Thank you outlook! @Outlookindia @SRIHER_Official @SRMC_official

Patient with acute retrosternal pain. It was aortic dissection. What else you see? It is a rare finding, may be one or 2 case reports only.

.@Drroxmehran will present the Vanguard lecture at #ANZET25 on “From Intervention to Prevention… A Lens to the Future.” Join her to learn about the latest advancements in interventional #cardiology. @thecsanz @IcahnMountSinai #CardioX

Join Dr. @georgedangas at #ANZET25 for his distinguished Louis Bernstein lecture on “Interventional Cardiology: Concept Evolution Through Evidence-Based Medicine” and hear updates on structural heart disease. @thecsanz @IcahnMountSinai #CardioX

Performing BASILICA: a step-by-step guide to prevent coronary obstruction during TAVI My toolkit 🧰⚙️🔨pcronline.com/Cases-resource… @Mo_A_W & Ahmed Abdelhafez share a proactive method to safely prevent coronary obstruction in high-risk TAVI patients. This clear, hands-on tutorial walks you through patient selection, key procedural steps, and tips to master this life-saving approach. Review & comment provided by @HenrykDreger @kiadeb87

Unstable angina patients with elevated #hsCRP levels (≥3 mg/L) are associated with sustained proinflammatory reprogramming of circulating monocytes, which contributes to residual inflammation and increased CV risk. jacc.org/doi/10.1016/j.jacbt… #JACCBTS #ASCVD #cvCAD

HFrEF to HFimRF. 30% it happens Those who had improved EF had less events ( mortality and worsening of HF) De-escalation of GDMT in HFimRF s modestly associated with clinical risk. @JACCJournals @hfsa @CsiChennai @SRIHER_Official @SubodhVermaMD @thePHFI @INDIACCDC @DrDPrabhakaran @ParasuramMD @drvenkat2517 @cardiosadha2 @RameshSank1975

Congratulations to Dr. Roxana Mehran (@Drroxmehran) on being elected the 2026 President of the American College of Cardiology @ACCinTouch. A visionary leader in interventional #cardiology, Dr. Mehran currently serves as Vice President and will assume the presidency in March 2026.